These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9514530)

  • 1. Interferon induces insulin resistance in patients with chronic active hepatitis C.
    Imano E; Kanda T; Ishigami Y; Kubota M; Ikeda M; Matsuhisa M; Kawamori R; Yamasaki Y
    J Hepatol; 1998 Feb; 28(2):189-93. PubMed ID: 9514530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of long-term interferon-alpha treatment on glucose tolerance in patients with chronic hepatitis C.
    Ito Y; Takeda N; Ishimori M; Akai A; Miura K; Yasuda K
    J Hepatol; 1999 Aug; 31(2):215-20. PubMed ID: 10453932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha reduces insulin resistance and beta-cell secretion in responders among patients with chronic hepatitis B and C.
    Tai TY; Lu JY; Chen CL; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS; Chuang LM; Jeng YM
    J Endocrinol; 2003 Sep; 178(3):457-65. PubMed ID: 12967337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired splanchnic and peripheral glucose uptake in liver cirrhosis.
    Imano E; Kanda T; Nakatani Y; Motomura M; Arai K; Matsuhisa M; Yamasaki Y; Hori M
    J Hepatol; 1999 Sep; 31(3):469-73. PubMed ID: 10488706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of factors controlling glucose tolerance in patients with HCV infection before and after 4 months therapy with interferon-alpha.
    Konrad T; Zeuzem S; Vicini P; Toffolo G; Briem D; Lormann J; Herrmann G; Berger A; Kusterer K; Teuber G; Cobelli C; Usadel KH
    Eur J Clin Invest; 2000 Feb; 30(2):111-21. PubMed ID: 10651835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-load insulin resistance does not predict virological response to treatment of chronic hepatitis C patients without the metabolic syndrome.
    Fattovich G; Baroni GS; Pasino M; Pierantonelli I; Covolo L; Ieluzzi D; Passigato N; Tonon A; Faraci MG; Guido M; Negro F
    Dig Liver Dis; 2012 May; 44(5):419-25. PubMed ID: 22277808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy.
    Lu JY; Chuang LM; Yang WS; Tai TY; Lai MY; Chen PJ; Kao JH; Lee CZ; Lee HS
    Liver Int; 2005 Aug; 25(4):752-9. PubMed ID: 15998426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of type 2 diabetes mellitus and glucose abnormalities in patients with chronic hepatitis C infection by response to treatment: results of a cohort study.
    Giordanino C; Bugianesi E; Smedile A; Ciancio A; Abate ML; Olivero A; Pellicano R; Cassader M; Gambino R; Bo S; Ciccone G; Rizzetto M; Saracco G
    Am J Gastroenterol; 2008 Oct; 103(10):2481-7. PubMed ID: 18702647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a.
    Nasta P; Gatti F; Puoti M; Cologni G; Bergamaschi V; Borghi F; Matti A; Ricci A; Carosi G
    AIDS; 2008 Apr; 22(7):857-61. PubMed ID: 18427204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
    Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
    Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients.
    Gastaldi G; Gomes D; Schneiter P; Montet X; Tappy L; Clément S; Negro F
    PLoS One; 2019; 14(6):e0217751. PubMed ID: 31170218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance and response to antiviral therapy in chronic hepatitis C: mechanisms and management.
    del Campo JA; López RA; Romero-Gómez M
    Dig Dis; 2010; 28(1):285-93. PubMed ID: 20460925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of stress hormones on splanchnic substrate and insulin disposal after glucose ingestion in healthy humans.
    Waldhäusl WK; Gasic S; Bratusch-Marrain P; Komjati M; Korn A
    Diabetes; 1987 Feb; 36(2):127-35. PubMed ID: 3542641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in glucose tolerance after interferon-alpha therapy in patients with chronic hepatitis C.
    Tanaka H; Shiota G; Kawasaki H
    J Med; 1997; 28(5-6):335-46. PubMed ID: 9604792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.
    Chavez AO; Coletta DK; Kamath S; Cromack DT; Monroy A; Folli F; DeFronzo RA; Tripathy D
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E758-64. PubMed ID: 19190263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of splanchnic and peripheral tissues in the pathogenesis of impaired glucose tolerance.
    Saccà L; Orofino G; Petrone A; Vigorito C
    J Clin Invest; 1984 Jun; 73(6):1683-7. PubMed ID: 6373828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C.
    Conjeevaram HS; Wahed AS; Afdhal N; Howell CD; Everhart JE; Hoofnagle JH;
    Gastroenterology; 2011 Feb; 140(2):469-77. PubMed ID: 21070775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral tissue glucose uptake is not reduced after an oral glucose load in Southern Italian subjects at risk of developing non-insulin-dependent diabetes mellitus.
    Thorburn AW; Proietto J
    Metabolism; 1999 Jan; 48(1):80-5. PubMed ID: 9920149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C.
    Negro F; Clément S
    J Viral Hepat; 2009 Oct; 16(10):681-8. PubMed ID: 19732324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT).
    Poynard T; Marcellin P; Lee SS; Niederau C; Minuk GS; Ideo G; Bain V; Heathcote J; Zeuzem S; Trepo C; Albrecht J
    Lancet; 1998 Oct; 352(9138):1426-32. PubMed ID: 9807989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.